Status:
UNKNOWN
Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Seven Oaks Hospital Chronic Disease Innovation Centre
Conditions:
Cardiometabolic Syndrome
Weight Loss
Eligibility:
All Genders
18+ years
Brief Summary
This is a pilot study evaluating an online cardiometabolic and weight loss program which is offered by The Wellness Institute. The program is 16 weeks and is developed by a multidisciplinary team and ...
Detailed Description
The Wellness Institute is offering a new cardiometabolic and weight loss program. It is a digital behavior change program designed to help clients achieve healthy weight reduction, thereby improving c...
Eligibility Criteria
Inclusion
- Program inclusion criteria:
- • Male or female, aged 18 years or above, have one or more of the following conditions: pre-diabetes, diabetes, high blood pressure, high triglycerides, low HDL, abdominal obesity, and BMI \>25 kg/m2.
- Program exclusion criteria:
- Female participant who is pregnant, lactating or planning pregnancy during the course of the program.
- Recent heart attack, stroke, heart surgery, and congestive heart failure.
- Participants who have unmanaged diabetes, chest pain or difficulty breathing.
Exclusion
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04784624
Start Date
March 1 2021
End Date
July 31 2022
Last Update
April 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chronic Disease Innovation Centre, Seven Oaks Hospital
Winnipeg, Manitoba, Canada, R2V 3M3